Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,925 | -18,909 | -70,520 | -48,288 | -31,983 |
| Depreciation Amortization | 55 | 23 | 77 | 57 | 40 |
| Accounts payable and accrued liabilities | 53 | 4,812 | 1,773 | 1,784 | 3,252 |
| Other Working Capital | -2,182 | -434 | 4,687 | 5,819 | 3,868 |
| Other Operating Activity | 5,914 | -2,022 | 5,584 | 3,280 | -275 |
| Operating Cash Flow | $-37,085 | $-16,530 | $-58,399 | $-37,348 | $-25,098 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -994 | -340 | -700 | -342 | -342 |
| Investing Cash Flow | $-994 | $-340 | $-700 | $-342 | $-342 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 322 | 218 | 112,908 | 112,884 | 113,051 |
| Other Financing Activity | -23 | -23 | -361 | 0 | 0 |
| Financing Cash Flow | $299 | $195 | $112,547 | $112,884 | $113,051 |
| Beginning Cash Position | 192,646 | 192,646 | 139,198 | 139,198 | 139,198 |
| End Cash Position | 154,866 | 175,971 | 192,646 | 214,392 | 226,809 |
| Net Cash Flow | $-37,780 | $-16,675 | $53,448 | $75,194 | $87,611 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,085 | -16,530 | -58,399 | -37,348 | -25,098 |
| Capital Expenditure | -994 | -340 | -700 | -342 | -342 |
| Free Cash Flow | -38,079 | -16,870 | -59,099 | -37,690 | -25,440 |